Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 1,326 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Validation Clear all

Conditions: Oral and Throat Cancer, Oropharyngeal Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma
Interventions: Oral/Throat cancer test; Device
Lead sponsor: Viome; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: St Louis, Missouri • Memphis, Tennessee

Conditions: Physical Trauma
Interventions: Trauma Specific Frailty Index Questionnaire; Diagnostic Test
Lead sponsor: Methodist Health System; Other
Eligibility: 65 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Contraception
Interventions: Log daily intercourse information, Natural Cycles application; Behavioral · Device
Lead sponsor: Natural Cycles; Industry
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Childhood Obesity, Bariatric Surgery Candidate
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 8 Years to 17 Years
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 60 Years to 85 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Computerized Assessment Feasibility and Validity
Interventions: HHT-G, HHT-D, Geriatric Depression Scale (DGS), MMSE; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 60 Years to 85 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Cancer, Solid Tumor, Hematologic Malignancy
Interventions: Not listed
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Sickle Cell Disease
Interventions: Not listed
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 6 Weeks to 60 Months
Enrollment: 738 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Omaha, Nebraska • Chapel Hill, North Carolina • Cleveland, Ohio

Conditions: Pain
Interventions: Not listed
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Metastatic Sarcoma, Recurrent Sarcoma, Sarcoma
Interventions: Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography, 18F-FDG; Procedure · Drug · Radiation
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dietary Habits
Interventions: Not listed
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 62 Years
Enrollment: 63 participants
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hypoxia
Interventions: Not listed
Lead sponsor: Nonin Medical, Inc; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Charcot Marie Tooth Disease
Interventions: Not listed
Lead sponsor: University of Iowa; Other
Eligibility: 8 Years and older
Enrollment: 291 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Mild Cognitive Impairment, Dementia
Interventions: neuropsychological testing, eSAGE testing; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 50 Years and older
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: COVID-19
Interventions: olfactory device; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 1,320 participants
Timeline: 2020
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Myopia
Interventions: Test Lens, Control Lens; Device
Lead sponsor: CooperVision, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Infiltration of Peripheral IV Therapy
Interventions: The ivWatch Model 400; Device
Lead sponsor: ivWatch, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Williamsburg, Virginia

Conditions: Atopic Dermatitis, Healthy Children
Interventions: Hydration Sensor; Device
Lead sponsor: Northwestern University; Other
Eligibility: Up to 18 Years
Enrollment: 172 participants
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Fluid Intake in Athletes, Sweating Rate in Athletes, Sweat Chloride Concentration in Athletes
Interventions: Smart Cap, running and fitness exercisers only, Sweat Patch, all subjects- running, fitness, cycling, Reference sweat patch, all subjects - running, fitness, cycling, Bottle Scale, all subjects - running, fitness, cycling; Device · Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 16 Years to 65 Years
Enrollment: 173 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Barrington, Illinois • Chicago, Illinois • Deer Park, Illinois

Conditions: Healthy
Interventions: Masimo INVSENSOR00073; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Irvine, California

Conditions: Platelet-Rich Plasma (PRP), Knee Osteoarthritis (OA)
Interventions: Intra-Articular knee injection of LC-PRP; Procedure
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Pain, Otitis Media
Interventions: benzocaine, placebo; Drug
Lead sponsor: Arbor Pharmaceuticals, Inc.; Industry
Eligibility: 2 Months to 4 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 15
States / cities: Jonesboro, Arkansas • Miami Beach, Florida • West Des Moines, Iowa + 11 more

Conditions: Sleep Apnea, Obstructive
Interventions: Trillium, AirFit F20; Device
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Bladder Cancer, Genitourinary Cancer, Prostate Cancer
Interventions: Ferumoxtran-10 (USPIO), MR lymphangiography; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Validity of Viome's Oral/throat Cancer Test

Trauma Specific Frailty Index

Validation of Effectiveness on NaturalCycles Users

Validation of Circulating Endothelial Cells and Microparticles in Youth

Neurotrack Test Validation Protocol

Feasibility and Validity of A Novel Computer Based Battery of Assessments in the Elderly

Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

Sickle Cell Disease, Hemechip

Behavioral Indicators of Pain:Tool Development With Concurrent and Construct Validity

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

PortionSize Study 3: Assessment in Free-living Conditions

Induced Hypoxia Study for Validation of SpO2 Accuracy

Development and Validation of a Disability Severity Index for CMT

Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects

Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses

ivWatch Model 400: Device Validation for Infiltrated Tissues

Hydration Sensor for Atopic Dermatitis

Validity of Smart Cap and Smart Sweat Patch

Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073

Validation of a Low-cost Platelet-Rich Plasma (PRP)

Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media

Trillium Validation Study

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast